Please enable JavaScript to continue using this application.

Compare $STOK vs $XNCR | Chartloom

Compare

$STOK vs $XNCR

Stoke Therapeutics Inc · Xencor Inc

STOK

Stoke Therapeutics Inc

XNCR

Xencor Inc

Compare $STOK vs $XNCR

Comparing Stoke Therapeutics Inc and Xencor Inc

STOKStoke Therapeutics Inc

XNCRXencor Inc

STOKStoke Therapeutics Inc

Market cap

$1.54B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

47.27x

Rev growth (TTM)

-86.2%

YTD performance

-19.9%

52W performance

-18.9%

FCF yield

-11.7%

XNCRXencor Inc

Market cap

$1.83B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

14.26x

Rev growth (TTM)

-33.2%

YTD performance

65.1%

52W performance

98.6%

FCF yield

-11.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

STOK

XNCR

Detailed metrics comparison

STOK

Stoke Therapeutics Inc

XNCR

Xencor Inc

Market Cap

STOK$1.54B

XNCR$1.83B

Enterprise Value

STOK$1.43B

XNCR$1.89B

Price

STOK$24.74

XNCR$24.63

P/E Ratio

STOKN/A

XNCRN/A

P/S Ratio

STOK55.85x

XNCR17.40x

EV/Sales

STOK51.86x

XNCR17.97x

EV/EBITDA

STOK53.69x

XNCR31.73x

P/B Ratio

STOK4.78x

XNCR3.71x

P/FCF Ratio

STOKN/A

XNCRN/A

EV/FCF

STOK-7.92x

XNCR-9.06x

PEG Ratio

STOKN/A

XNCRN/A

Forward P/E (NTM)

STOKN/A

XNCRN/A

Forward P/S (NTM)

STOK47.27x

XNCR14.26x

Revenue (TTM)

STOK$28M

XNCR$105M

Revenue Growth (YoY)

STOK-86.2%

XNCR-33.2%

Forward Rev Growth

STOK62.9%

XNCR7.4%

Gross Margin (TTM)

STOK0.0%

XNCR0.0%

Operating Margin (TTM)

STOK0.0%

XNCR0.0%

EBITDA Margin (TTM)

STOK-803.4%

XNCR-188.5%

Net Margin (TTM)

STOK-753.6%

XNCR-155.6%

FCF Margin (TTM)

STOK-654.9%

XNCR-198.4%

Net Income (TTM)

STOK$-208M

XNCR$-163M

FCF (TTM)

STOK$-181M

XNCR$-208M

EPS (TTM)

STOK-$3.15

XNCR-$2.15

ROE (TTM)

STOK-5936.0%

XNCR-2866.0%

ROA (TTM)

STOK-5146.0%

XNCR-2038.0%

ROIC (TTM)

STOK-5936.0%

XNCR-2379.0%

Cash

STOK$110M

XNCR$45M

Debt

STOK$0

XNCR$105M

Net Cash/Debt

STOK$110M

XNCR$-60M

Current Ratio (TTM)

STOK7.69x

XNCR6.39x

Quick Ratio (TTM)

STOK7.34x

XNCR6.09x

Debt/Equity (TTM)

STOK0.00x

XNCR0.21x

Debt/Assets (TTM)

STOK0.0%

XNCR0.0%

Interest Coverage (TTM)

STOKN/A

XNCRN/A

Net Debt/EBITDA (TTM)

STOK0.00x

XNCR0.00x

Beta

STOK1.36

XNCR0.81

52W Performance

STOK-18.9%

XNCR98.6%

YTD Performance

STOK-19.9%

XNCR65.1%

% from 52W High

STOK-38.5%

XNCR-19.5%

% from 52W Low

STOK21.8%

XNCR137.4%

Asset Turnover (TTM)

STOK0.07x

XNCR0.13x

FCF Yield (TTM)

STOK-11.7%

XNCR-11.4%

Earnings Yield (TTM)

STOK-13.5%

XNCR-8.9%

Dividend Yield (TTM)

STOKN/A

XNCRN/A

Rule of 40

STOK-741.1

XNCR-231.6

EV/GP/RG

STOKN/A

XNCRN/A

Ticker research

View STOK research View XNCR research

Metric	STOK Stoke Therapeutics Inc	XNCR Xencor Inc
Market & Valuation
Market Cap	$1.54B	$1.83B
Enterprise Value	$1.43B	$1.89B
Price	$24.74	$24.63
P/E Ratio	N/A	N/A
P/S Ratio	55.85x	17.40x
EV/Sales	51.86x	17.97x
EV/EBITDA	53.69x	31.73x
P/B Ratio	4.78x	3.71x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.92x	-9.06x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	47.27x	14.26x
Revenue & Growth
Revenue (TTM)	$28M	$105M
Revenue Growth (YoY)	-86.2%	-33.2%
Forward Rev Growth	62.9%	7.4%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-803.4%	-188.5%
Net Margin (TTM)	-753.6%	-155.6%
FCF Margin (TTM)	-654.9%	-198.4%
Net Income (TTM)	$-208M	$-163M
FCF (TTM)	$-181M	$-208M
EPS (TTM)	-$3.15	-$2.15
ROE (TTM)	-5936.0%	-2866.0%
ROA (TTM)	-5146.0%	-2038.0%
ROIC (TTM)	-5936.0%	-2379.0%
Financial Health
Cash	$110M	$45M
Debt	$0	$105M
Net Cash/Debt	$110M	$-60M
Current Ratio (TTM)	7.69x	6.39x
Quick Ratio (TTM)	7.34x	6.09x
Debt/Equity (TTM)	0.00x	0.21x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.36	0.81
52W Performance	-18.9%	98.6%
YTD Performance	-19.9%	65.1%
% from 52W High	-38.5%	-19.5%
% from 52W Low	21.8%	137.4%
Efficiency & Yields
Asset Turnover (TTM)	0.07x	0.13x
FCF Yield (TTM)	-11.7%	-11.4%
Earnings Yield (TTM)	-13.5%	-8.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-741.1	-231.6
EV/GP/RG	N/A	N/A
Ticker research	View STOK research	View XNCR research

Valuation

P/S Ratio

XNCR

17.40x

STOK

55.85x

EV/FCF

XNCR

-9.06x

STOK

-7.92x

Growth & revenue

Revenue Growth TTM

XNCR

-33.2%

STOK

-86.2%

Forward Revenue Growth

STOK

62.9%

XNCR

7.4%

Profitability & performance

Gross Margin

STOK

0.0%

XNCR

0.0%

ROE

XNCR

-2866.0%

STOK

-5936.0%

FCF Yield %

XNCR

-11.4%

STOK

-11.7%

52-Week Performance

XNCR

98.6%

STOK

-18.9%

Detailed metrics comparison

STOK

Stoke Therapeutics Inc

XNCR

Xencor Inc

Market Cap

STOK$1.54B

XNCR$1.83B

Enterprise Value

STOK$1.43B

XNCR$1.89B

Price

STOK$24.74

XNCR$24.63

P/E Ratio

STOKN/A

XNCRN/A

P/S Ratio

STOK55.85x

XNCR17.40x

EV/Sales

STOK51.86x

XNCR17.97x

EV/EBITDA

STOK53.69x

XNCR31.73x

P/B Ratio

STOK4.78x

XNCR3.71x

P/FCF Ratio

STOKN/A

XNCRN/A

EV/FCF

STOK-7.92x

XNCR-9.06x

PEG Ratio

STOKN/A

XNCRN/A

Forward P/E (NTM)

STOKN/A

XNCRN/A

Forward P/S (NTM)

STOK47.27x

XNCR14.26x

Revenue (TTM)

STOK$28M

XNCR$105M

Revenue Growth (YoY)

STOK-86.2%

XNCR-33.2%

Forward Rev Growth

STOK62.9%

XNCR7.4%

Gross Margin (TTM)

STOK0.0%

XNCR0.0%

Operating Margin (TTM)

STOK0.0%

XNCR0.0%

EBITDA Margin (TTM)

STOK-803.4%

XNCR-188.5%

Net Margin (TTM)

STOK-753.6%

XNCR-155.6%

FCF Margin (TTM)

STOK-654.9%

XNCR-198.4%

Net Income (TTM)

STOK$-208M

XNCR$-163M

FCF (TTM)

STOK$-181M

XNCR$-208M

EPS (TTM)

STOK-$3.15

XNCR-$2.15

ROE (TTM)

STOK-5936.0%

XNCR-2866.0%

ROA (TTM)

STOK-5146.0%

XNCR-2038.0%

ROIC (TTM)

STOK-5936.0%

XNCR-2379.0%

Cash

STOK$110M

XNCR$45M

Debt

STOK$0

XNCR$105M

Net Cash/Debt

STOK$110M

XNCR$-60M

Current Ratio (TTM)

STOK7.69x

XNCR6.39x

Quick Ratio (TTM)

STOK7.34x

XNCR6.09x

Debt/Equity (TTM)

STOK0.00x

XNCR0.21x

Debt/Assets (TTM)

STOK0.0%

XNCR0.0%

Interest Coverage (TTM)

STOKN/A

XNCRN/A

Net Debt/EBITDA (TTM)

STOK0.00x

XNCR0.00x

Beta

STOK1.36

XNCR0.81

52W Performance

STOK-18.9%

XNCR98.6%

YTD Performance

STOK-19.9%

XNCR65.1%

% from 52W High

STOK-38.5%

XNCR-19.5%

% from 52W Low

STOK21.8%

XNCR137.4%

Asset Turnover (TTM)

STOK0.07x

XNCR0.13x

FCF Yield (TTM)

STOK-11.7%

XNCR-11.4%

Earnings Yield (TTM)

STOK-13.5%

XNCR-8.9%

Dividend Yield (TTM)

STOKN/A

XNCRN/A

Rule of 40

STOK-741.1

XNCR-231.6

EV/GP/RG

STOKN/A

XNCRN/A

Ticker research

View STOK research View XNCR research

Metric	STOK Stoke Therapeutics Inc	XNCR Xencor Inc
Market & Valuation
Market Cap	$1.54B	$1.83B
Enterprise Value	$1.43B	$1.89B
Price	$24.74	$24.63
P/E Ratio	N/A	N/A
P/S Ratio	55.85x	17.40x
EV/Sales	51.86x	17.97x
EV/EBITDA	53.69x	31.73x
P/B Ratio	4.78x	3.71x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.92x	-9.06x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	47.27x	14.26x
Revenue & Growth
Revenue (TTM)	$28M	$105M
Revenue Growth (YoY)	-86.2%	-33.2%
Forward Rev Growth	62.9%	7.4%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-803.4%	-188.5%
Net Margin (TTM)	-753.6%	-155.6%
FCF Margin (TTM)	-654.9%	-198.4%
Net Income (TTM)	$-208M	$-163M
FCF (TTM)	$-181M	$-208M
EPS (TTM)	-$3.15	-$2.15
ROE (TTM)	-5936.0%	-2866.0%
ROA (TTM)	-5146.0%	-2038.0%
ROIC (TTM)	-5936.0%	-2379.0%
Financial Health
Cash	$110M	$45M
Debt	$0	$105M
Net Cash/Debt	$110M	$-60M
Current Ratio (TTM)	7.69x	6.39x
Quick Ratio (TTM)	7.34x	6.09x
Debt/Equity (TTM)	0.00x	0.21x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.36	0.81
52W Performance	-18.9%	98.6%
YTD Performance	-19.9%	65.1%
% from 52W High	-38.5%	-19.5%
% from 52W Low	21.8%	137.4%
Efficiency & Yields
Asset Turnover (TTM)	0.07x	0.13x
FCF Yield (TTM)	-11.7%	-11.4%
Earnings Yield (TTM)	-13.5%	-8.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-741.1	-231.6
EV/GP/RG	N/A	N/A
Ticker research	View STOK research	View XNCR research